权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Technology Core

技术核心

基本信息

批准号：
9901440
负责人：
Julie Dunning Hotopp
金额：
$ 50.48万
依托单位：
UNIVERSITY OF MARYLAND BALTIMORE
依托单位国家：
美国
项目类别：
财政年份：
资助国家：
美国
起止时间：
至
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/9901440
关键词：
Adopted Algorithms Animal Model Area Bacteria Biological Sciences Buffers CRISPR/Cas technology Cells Chromium Code Communicable Diseases Communities Custom Cytolysis Data Development Disease Outcome Ensure Evaluation Future Gene Expression Profiling Genome Genomics Gold Human Invertebrates Investigation Investments Libraries Methodology Methods Modification Operon Organism Parasites Pilot Projects Plasmodium Poly A Procedures Production Protocols documentation RNA Research Research Personnel Research Project Grants Resources Ribosomal RNA Sampling Sequence Analysis Small RNA Techniques Technology Testing Time Tissue-Specific Gene Expression Transcript Transfer RNA Variant Viral Virus Work WormBase analysis pipeline base bioinformatics tool biological systems cost data analysis pipeline data warehouse experience experimental study fungus genome analysis genome annotation genome editing genome sequencing high standard human model improved innovation metagenome metatranscriptome microbiome nanopore novel open source pathogen research and development sequencing platform single cell sequencing single-cell RNA sequencing tool transcriptome transcriptome sequencing transcriptomics vector

项目摘要

Through the activities in this Technology Core, we will provide comprehensive high-throughput genome sequencing and analysis to the investigators participating in this U19 proposal to advance research in all four projects that are focused on understanding host, pathogen, and microbiome interactions as determinants of infectious disease outcome. We will provide standard high throughput genome, transcriptome, metagenome, metatranscriptome, and single cell sequencing as well as other standard sequencing methods required by our Viral, Bacterial, Fungal, and Parasite research projects and any future collaborative pilot projects. This includes sequencing on every major sequencing platform including Illumina, Pacific Biosciences, and Oxford Nanopore. We will also provide custom sequencing approaches for the study of infectious disease, when necessary, building on our immense experience on sequence and analysis of polymicrobial samples. We will use the latest sequencing and analysis tools to improve genome annotation, providing an important resource to the infectious disease community. We will focus our research and development activities on developing a robust single cell transcriptomics for the analysis of host-pathogen samples, including single cell transcriptomics on prokaryotic pathogens lacking polyadenylated transcripts. We will encourage and support the implementation and analysis of genome editing approaches that are described within the projects. Lastly, we will integrate our Technology and Data Cores to seamlessly transition sequencing data and novel analysis tools generated in the Technology Core to the Data Core.

通过这个技术核心的活动，我们将提供全面的高通量基因组对参与这项U19提案的研究人员进行测序和分析，以推进所有四项研究专注于了解宿主、病原体和微生物群相互作用作为决定因素的项目传染病结局。我们将提供标准的高通量基因组、转录组、元基因组、和单细胞测序以及我们所需的其他标准测序方法病毒、细菌、真菌和寄生虫研究项目以及未来的任何合作试点项目。这包括在每个主要测序平台上进行测序，包括Illumina、Pacific Biosciences和Oxford 纳米孔。我们还将为传染病的研究提供定制的测序方法，当根据我们在多个微生物样本的测序和分析方面的丰富经验，这是必要的。我们会使用最新的测序和分析工具改进基因组注释，为以下方面提供重要资源传染病社区。我们将把研发活动的重点放在开发一种用于包括单细胞在内的寄主病原体样本分析的强健的单细胞转录切割技术原核病原体缺乏多聚腺苷化转录本的转录组学。我们将鼓励和支持项目中描述的基因组编辑方法的实施和分析。最后，我们将整合我们的技术和数据核心，以无缝转换测序数据和新颖的从技术核心到数据核心生成的分析工具。